News
Zornitza Stefanova, founder and CEO of BSPK, has been featured in Forbes Tech Council with a compelling new article titled“Beyond CRM: How Clienteling Builds Personal Relationships At Scale” .
The article by Ailawadhi et al titled “Isatuximab Subcutaneous by On-Body Injector Versus Isatuximab Intravenous Plus Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma: Phase III ...
Risk management news: the latest regulation and compliance updates and advice from the Wall Street Journal.
Erratum: Isatuximab Subcutaneous by On-Body Injector Versus Isatuximab Intravenous Plus Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma: Phase III IRAKLIA Study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback